Dec 30, 2025 • MarketBeat
NEUTRAL
Muzinich & Co. Inc. Purchases 254,651 Shares of Hercules Capital, Inc. $HTGC
Muzinich & Co. Inc. significantly increased its stake in Hercules Capital, Inc. (NYSE:HTGC) by 34.5% during the third quarter, acquiring 254,651 new shares to hold a total of 992,820 shares valued at approximately $18.77 million. This move makes HTGC the sixth-largest position in Muzinich & Co. Inc.'s portfolio, representing about 0.55% of Hercules Capital. Despite mixed analyst ratings, with a "Moderate Buy" consensus, Hercules Capital recently paid a quarterly dividend of $0.40, equating to an 8.6% yield.
Dec 25, 2025 • MarketBeat
NEUTRAL
Confluence Investment Management LLC Trims Stake in Hercules Capital, Inc. $HTGC
Confluence Investment Management LLC reduced its stake in Hercules Capital, Inc. (NYSE:HTGC) by 21.2% in the third quarter, selling 81,265 shares and retaining 302,513 shares valued at $5.72 million. Despite this, Hercules Capital maintains a "Moderate Buy" consensus target price of $20.32 from analysts and offers a high dividend yield of 8.7%. Insider confidence is also indicated by a director's recent purchase of 6,000 shares.
Dec 23, 2025 • TMX Newsfile
NEUTRAL
Adaptimmune Secures up to $125 Million Debt Financing with Hercules Capital
Adaptimmune Therapeutics plc has secured up to $125 million in a five-year term loan facility with Hercules Capital to strengthen its balance sheet and support the commercial launch of afami-cel and lete-cel. An initial $25 million tranche is available immediately, with additional funds contingent on afami-cel approval and other conditions. The financing will help advance Adaptimmune's cell therapy development for solid tumor cancers.
Dec 23, 2025 • MarketBeat
BULLISH
Hercules Capital, Inc. (NYSE:HTGC) Receives Consensus Rating of "Moderate Buy" from Analysts
Hercules Capital, Inc. (NYSE:HTGC) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $20.32. The company recently reported strong quarterly earnings, slightly beating revenue and EPS estimates, and declared a quarterly dividend of $0.40, offering an 8.7% yield. Insider activity also shows director Gayle A. Crowell increasing her stake in the company.
Dec 22, 2025 • Seeking Alpha
SOMEWHAT-BULLISH
Trinity Capital: 102% Coverage, Strong Growth, Moderate Premium (TRIN)
Trinity Capital (TRIN) is highlighted as a tech-focused Business Development Company (BDC) demonstrating strong portfolio growth, a low non-accrual rate (1.0%), and a 102% dividend coverage ratio for its $0.51 dividend. The company's shares are currently trading at a moderate premium, slightly above its 3-year average P/NAV ratio. The author suggests considering a purchase if the share price drops below their fair value estimate of $14.70/share.
Dec 21, 2025 • MarketBeat
NEUTRAL
Sound Income Strategies LLC Has $52.06 Million Stock Holdings in Hercules Capital, Inc. $HTGC
Sound Income Strategies LLC reduced its stake in Hercules Capital, Inc. (NYSE:HTGC) by 6.1% in Q3, now holding 2,752,867 shares valued at approximately $52.06 million, making it their largest position. Hercules Capital currently has a "Moderate Buy" consensus rating from analysts, with a target price of $20.32, despite a high dividend payout ratio of 93.02%. Insider activity shows Director Gayle A. Crowell recently acquired 6,000 shares, increasing her direct ownership to 78,727 shares.